Abstract:Intra-organism biodiversity is thought to arise from epigenetic modification of constituent genes and post-translational modifications of translated proteins. Here, we show that post-transcriptional modifications, like RNA editing, may also contribute. RNA editing enzymes APOBEC3A and APOBEC3G catalyze the deamination of cytosine to uracil. RNAsee (RNA site editing evaluation) is a computational tool developed to predict the cytosines edited by these enzymes. We find that 4.5% of non-synonymous DNA single nucleotide polymorphisms that result in cytosine to uracil changes in RNA are probable sites for APOBEC3A/G RNA editing; the variant proteins created by such polymorphisms may also result from transient RNA editing. These polymorphisms are associated with over 20% of Medical Subject Headings across ten categories of disease, including nutritional and metabolic, neoplastic, cardiovascular, and nervous system diseases. Because RNA editing is transient and not organism-wide, future work is necessary to confirm the extent and effects of such editing in humans.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the impact of APOBEC3 - mediated C - to - U RNA editing on human diseases. Specifically, by developing a computational tool named RNAsee, the researchers predicted the possible RNA editing sites of APOBEC3A and APOBEC3G enzymes in human gene transcripts and analyzed the relationship between these editing sites and known human protein variants, especially those that may cause diseases. The main objective of the study was to evaluate whether and how C - to - U RNA editing affects human health, especially the potential impact in areas such as neurodegenerative diseases, metabolic diseases, and tumors. ### Research Background - **RNA Editing**: RNA editing refers to any change at a specific position in the RNA sequence. This change is not caused by the template replication process but is completed by specific enzyme catalysis. Among them, enzymes in the APOBEC3 family can catalyze the deamination reaction from cytosine (C) to uracil (U). - **APOBEC3A and APOBEC3G**: These two enzymes mainly catalyze the C - to - U conversion in single - stranded RNA or single - stranded DNA. Although they were initially found to act in viral DNA, researchers speculate that they may also play a role in RNA editing for human health. ### Research Methods - **RNAsee Tool**: The researchers developed a computational tool named RNAsee to predict the editing sites of APOBEC3A and APOBEC3G in human gene transcripts. This tool combines machine - learning and rule - based methods. - **Data Sources**: The researchers extracted known non - synonymous single - nucleotide polymorphisms (SNPs) from the ClinVar database and screened out SNPs that may cause C - to - U changes. - **Performance Evaluation**: Through benchmark tests, the performance of RNAsee in predicting editing sites was evaluated, including metrics such as recall, precision, F1 - score, and Matthews correlation coefficient (MCC). ### Main Findings - **Prediction of Editing Sites**: The researchers found that approximately 4.5% of the known SNPs that cause C - to - U changes may be the editing sites of APOBEC3A/G. - **Disease Association**: These editing sites are associated with multiple diseases, including nutritional and metabolic diseases, tumors, cardiovascular diseases, and nervous system diseases. In particular, the proportion of editing sites is relatively high in neurodegenerative diseases and metabolic diseases. - **Potential Impact**: The researchers believe that APOBEC3 - mediated RNA editing may increase under certain conditions (such as inflammation, hypoxia, etc.), thereby producing variant proteins and affecting the functions of cells and tissues. ### Conclusion This study provides preliminary evidence indicating that APOBEC3A/G - mediated C - to - U RNA editing may have an important impact on human health. Future research needs to further verify the actual occurrence frequency of these editing events and their specific impact on human diseases.

The implications of APOBEC3-mediated C-to-U RNA editing for human disease